|
2013 Conference Publication Locoregional disease control in metastatic melanoma: Exploratory analysis from phase 2 testing of intralesional rose bengalAgarwala, S., Thompson, J. F., Smithers, B. M., Ross, M. I., Coventry, B. J., Minor, D. R., Scoggins, C. R., Singer, J. M. and Wachter, E. A. (2013). Locoregional disease control in metastatic melanoma: Exploratory analysis from phase 2 testing of intralesional rose bengal. 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity, Amsterdam Netherlands, Sep 27-Oct 01, 2013. Oxford United Kingdom: Pergamon. doi: 10.1016/S0959-8049(13)70065-0 |
|
2013 Journal Article Impact of postoperative morbidity on long-term survival after oesophagectomyHii, M. W., Smithers, B. M., Gotley, D. C., Thomas, J. M., Thomson, I., Martin, I. and Barbour, A. P. (2013). Impact of postoperative morbidity on long-term survival after oesophagectomy. British Journal of Surgery, 100 (1), 95-104. doi: 10.1002/bjs.8973 |
|
2013 Book Chapter Esophagus carcinoma surveillance counter: AustraliaSmithers, Bernard Mark, Thomas, Janine M. and Burmeister, Bryan H. (2013). Esophagus carcinoma surveillance counter: Australia. Patient Surveillance after Cancer Treatment. (pp. 97-100) edited by Frank Johnson, Yoshihiko Maehara, George P. Browman, Julie A. Margenthaler, Riccardo A. Audisio, John F. Thompson, David Y. Johnson, Craig C. Earle and Katerine S. Virgo. New York, United States: Humana Press. doi: 10.1007/978-1-60327-969-7_17 |
|
2013 Conference Publication Pilot multi-marker analysis to evaluate prognosis in stage Ib and II melanomasRowe, C. J., Rodero, M., Malt, M., Smithers, M., Green, A. and Khosrotehrani, K. (2013). Pilot multi-marker analysis to evaluate prognosis in stage Ib and II melanomas. The Australasian College of Dermatologists 46th Annual Scientific Meeting, Sydney, NSW Australia, 19 – 22 May 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12051 |
|
2013 Conference Publication Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy of autoimmune diseaseBurton, B. R., Britton, G. J., Fang, H., Verhagen, J., Smithers, B., Sabatos-Peyton, C. A., Carney, L. J., Gough, J., Strobel, S. and Wraith, C. (2013). Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy of autoimmune disease. Annual Congress of the British-Society-for-Immunology, Liverpool England, Dec 02-05, 2013. West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/imm.12217 |
|
2012 Journal Article Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian communityPandeya, N., Green, A. C., Whiteman, D. C., The Australian Cancer Study and Smithers, B. M. (2012). Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community. Diseases of the Esophagus, 25 (7), 573-583. doi: 10.1111/j.1442-2050.2011.01287.x |
|
2012 Journal Article Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasiaGordon, Louisa G., Hirst, Nicholas G., Mayne, George C., Watson, David I., Bright, Timothy, Cai, Wang, Barbour, Andrew P., Smithers, Bernard M., Whiteman, David C. and Eckermann, Simon (2012). Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia. Journal of Gastrointestinal Surgery, 16 (8), 1451-1461. doi: 10.1007/s11605-012-1911-9 |
|
2012 Journal Article Metastasectomy for distant metastatic melanoma: analysis of data from the first multicenter selective lymphadenectomy trial (MSLT-I)Howard, J. Harrison, Thompson, John F., Mozzillo, Nicola, Nieweg, Omgo E., Hoekstra, Harald J., Roses, Daniel F., Sondak, Vernon K., Reintgen, Douglas S., Kashani-Sabet, Mohammed, Karakousis, Constantine P., Coventry, Brendon J., Kraybill, William G., Smithers, B. Mark, Elashoff, Robert, Stern, Stacey L., Cochran, Alistair J., Faries, Mark B. and Morton, Donald L. (2012). Metastasectomy for distant metastatic melanoma: analysis of data from the first multicenter selective lymphadenectomy trial (MSLT-I). Annals of Surgical Oncology, 19 (8), 2547-2555. doi: 10.1245/s10434-012-2398-z |
|
2012 Journal Article Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBurmeister, Bryan H., Henderson, Michael A., Ainslie, Jill, Fisher, Richard, Di Iulio, Juliana, Smithers, B. Mark, Hong, Angela, Shannon, Kerwin, Scolyer, Richard A., Carruthers, Scott, Coventry, Brendon J., Babington, Scott, Duprat, Joao, Hoekstra, Harald J. and Thompson, John F. (2012). Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncology, 13 (6), 589-597. doi: 10.1016/S1470-2045(12)70138-9 |
|
2012 Journal Article An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissectionFoote, Matthew, Burmeister, Bryan, Dwyer, Patrick, Burmeister, Elizabeth, Lambie, Duncan, Allan, Christopher, Barbour, Andrew, Bayley, Gerard, Pullar, Andrew, Meakin, Janelle, Thomas, Janine and Smithers, Mark (2012). An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection. Melanoma Research, 22 (3), 257-262. doi: 10.1097/CMR.0b013e3283531335 |
|
2012 Conference Publication TOPGEAR: An international randomized phase III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (AGITG/TROG/EORTC/NCIC CTG)Leong, Trevor, Smithers, Mark, Michael, Michael, Gebski, Val, Boussioutas, Alex, Miller, Danielle, Zalcberg, John Raymond, Wong, Rebecca and Haustermans, Karin (2012). TOPGEAR: An international randomized phase III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (AGITG/TROG/EORTC/NCIC CTG). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2012 Journal Article Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, AustraliaGreen, Adele C., Baade, Peter, Coory, Michael, Aitken, Joanne F. and Smithers, Mark (2012). Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. Journal of Clinical Oncology, 30 (13), 1462-1467. doi: 10.1200/JCO.2011.38.8561 |
|
2012 Conference Publication TOPGEAR: An international randomized phase III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (AGITG/TROG/EORTC/NCIC CTG)Leong, Trevor, Smithers, Mark, Michael, Michael, Gebski, Val, Boussioutas, Alex, Miller, Danielle, Zalcberg, John Raymond, Wong, Rebecca and Haustermans, Karin (2012). TOPGEAR: An international randomized phase III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (AGITG/TROG/EORTC/NCIC CTG). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2012 Conference Publication Long-term cure after complete resection and adjuvant immunotherapy for distant melanoma metastasesMorton, Donald L., Mozzillo, Nicola, Kashani-Sabet, Mohammed, Thompson, John F., Kelley, Mark C., De Conti, Ronald C., Lee, Jeffrey Edwin, Huth, James F., Faries, Mark B., Dalgleish, Angus George, Wagner, Jeffrey D., Hersh, Evan, Schneebaum, Schlomo, Anderson, Clay M., Smithers, Mark, Schuchter, Lynn Mara, McMasters, Kelly M., Testori, Alessandro, Karakousis, C. P. and Elashoff, Robert (2012). Long-term cure after complete resection and adjuvant immunotherapy for distant melanoma metastases. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2012 Journal Article Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junctionThrift, Aaron P., Nagle, Christina M., Fahey, Paul P., Smithers, Bernard M., Watson, David I. and Whiteman, David C. (2012). Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junction. Cancer Causes and Control, 23 (4), 555-564. doi: 10.1007/s10552-012-9913-1 |
|
2012 Conference Publication DOCTOR: A randomized phase II trial of preoperative cisplatin, 5-fluorouracil, and docetaxel with or without radiotherapy based on poor early response to standard chemotherapy for resectable adenocarcinoma of the esophagus and/or OG junctionBarbour, Andrew, Smithers, Bernard Mark, Burmeister, Bryan, Zalcberg, John Raymond, Spry, Nigel, Smith, Garrett, Wilson, Kate, Roff, Kate, Yip, Sonia and Walpole, Euan Thomas (2012). DOCTOR: A randomized phase II trial of preoperative cisplatin, 5-fluorouracil, and docetaxel with or without radiotherapy based on poor early response to standard chemotherapy for resectable adenocarcinoma of the esophagus and/or OG junction. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il United States, 01-06 June 2012. Alexandria, VA United States: American Society of Clinical Oncology. |
|
2012 Conference Publication Immuno-chemoablation of metastatic melanoma with intralesional Rose BengalAgarwala, S. S., Thompson, J. F., Smithers, B. M., Ross, M., Coventry, B. J., Minor, D. R., Scoggins, C. R. and Wachter, E. (2012). Immuno-chemoablation of metastatic melanoma with intralesional Rose Bengal. 37th Congress of the European Society for Medical Oncology (ESMO), Vienna Austria, 28 September-02 October 2012. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mds404 |
|
2012 Journal Article The influence of pre-diagnostic demographic and lifestyle factors on oesophageal squamous cell carcinoma survivalThrift, Aaron P., Nagle, Christina M., Fahey, Paul P., Russell, Anne, Smithers, Bernard M., Watson, David I., Whiteman, David C. and for the Australian Cancer Study Clinical Follow-Up Study (2012). The influence of pre-diagnostic demographic and lifestyle factors on oesophageal squamous cell carcinoma survival. International Journal of Cancer, Early online (5), 1-29. doi: 10.1002/ijc.27420 |
|
2012 Conference Publication Activation of stat5 is an indicator of good prognosis in stage Ib and II melanomasRodero, M., Wright, A., Malt, M., Smithers, M., Green, A. and Khosrotehrani, K. (2012). Activation of stat5 is an indicator of good prognosis in stage Ib and II melanomas. The Australasian College of Dermatologists 45th Annual Scientific Meeting, Brisbane, QLD, Australia, 20-23 May 2012. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-0960.2012.00892.x |
|
2012 Conference Publication MAGE-A3 expression in patients screened for the DERMA trial: a phase III trial testing MAGE-A3 immunotherapeutic in the adjuvant setting for stage IIIB-C-Tx melanomaThompson, John F., Santinami, Mario, Jouary, Thomas, Levchenko, Eugeny, Smithers, Bernard Mark, Mortier, Laurent, Grob, Jean Jacques, Trefzer, Uwe, Gutzmer, Ralf, Jamoul, Corinne, Peeters, Olivier, Dreno, Brigitte and Kirkwood, John M. (2012). MAGE-A3 expression in patients screened for the DERMA trial: a phase III trial testing MAGE-A3 immunotherapeutic in the adjuvant setting for stage IIIB-C-Tx melanoma. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Illinois, 1-6 June 2012 . Alexandria, VA, United States : American Society of Clinical Oncology. |
